Godrej Consumer Products, DMart, Nykaa: Should you buy, sell or hold stocks in focus today?

Which stocks to buy, hold or sell today? As Dalal Street enters the April 6 session, here's a look at what brokerages make of some of the key stocks that are hogging the limelight.

Stocks such as Avenue Supermarts (DMart), Godrej Consumer Products, Cholamandalam Finance, Nykaa, and other pharma, bank shares are on their radar today.

Do you have any of these stocks in your portfolio?

Check out the full list of what brokerages recommend, including Avenue Supermarts (DMart), Godrej Consumer Products, Cholamandalam Finance, Nykaa, and other pharma and bank stocks:

Avenue Supermarts (DMart) shares

Global brokerages are divided on DMart operator Avenue Supermarts a day after the retail chain company announced its business update for the March quarter of the financial year 2022-23 (FY23).

Morgan Stanley maintained an ‘equal weight’ stance and Macquarie has an outperform rating on Avenue Supermarts.

On the contrary, Citi retains a ‘sell’ call on Avenue Supermarts as it remains cautious at current valuations given the risk around margins growth.

Godrej Consumer Products shares

Brokerages are upbeat on Godrej Consumer Products a day after the company announced its March quarter business update on Wednesday. Citi and Nomura each have a ‘buy’ rating, while Macquarie maintained an ‘outperform’ stance on the stock.

 According to Nomura, Godrej Consumer has shown strong performance on volumes and margins improvement is on track as well as the revenue growth also improved to double digits year-on-year. 

Cholamandalam Investment and Finance shares

Brokerages are bullish on Cholamandalam Investment and Finance Company as Morgan Stanley maintained an ‘equal weight’, while Jefferies and Citi each have a ‘buy’ rating on the stock.

The finance company’s disbursements grew at 20 per cent sequentially and 65 per cent YoY, this is higher than Morgan Stanley’s estimates. The brokerage raises FY23-25 earnings forecasts by 2-3 per cent. 

FSN E-Commerce Ventures (Nykaa) shares

Macquarie on Pharma stocks

Catch the latest updates on the first RBI policy review of the new financial year.

Catch the latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.

(Disclaimer: The views/suggestions/advice expressed here in this article is solely by investment experts. Zee Business suggests its readers consult with their investment advisers before making any financial decision.)